25 May 2013
Keywords: india, shanta, launch, new, products, biotechnics, hyderabad
Article | 31 August 2001
Shanta Biotechnics of Hyderabad, India, which produces the hepatitis Bvaccine Shanvac-B, says it intends to market four more products by 2002.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 September 2001
24 May 2013
© 2013 thepharmaletter.com